American Cancer Society BrightEdge Fund

Venture Capital

Impact venture capital arm of the American Cancer Society investing in cancer-fighting startups and health innovation.

Atlanta, United States · 4+ investments · 3 portfolio companies

Seed
Early Stage
Biotech
Oncology
health technology
Headquarters
Atlanta, United States
Website
cancer.org
Portfolio Companies
3
Total Investments
4
Last Investment
Dec 2025
Geographic Focus
United States

Investment Thesis

Support early-stage companies developing breakthrough cancer solutions, leveraging ACS mission and network to accelerate innovation in oncology and health technology.

American Cancer Society BrightEdge Fund is a Venture Capital firm based in Atlanta, United States. It has made 4 investments, including Cellens Inc, Predicta Biosciences and Castle Biosciences. Focus areas include Biotech and Oncology.

Portfolio3

Co-investors20

Sign up to view co-investors

20 co-investors across 13 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×16 · Accelerator ×2 · Corporate VC ×1 · 14 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

American Cancer Society BrightEdge Fund on Indexed.vc
<a href="https://indexed.vc/investors/american-cancer-society-brightedge-fund"><img src="https://indexed.vc/api/badge/investor/american-cancer-society-brightedge-fund" alt="American Cancer Society BrightEdge Fund on Indexed.vc" width="260" height="76" /></a>